Medical Research
(H124)
IRS Verified
DX Registered
990 on File
THE ASSOCIATION FOR FRONTOTEMPORAL DEGENERATION
Financial strength (30%)
79/100
Reliability (20%)
55/100
Effectiveness (25%)
88/100
Impact (25%)
No data yet
CharityAI™ Score
Not yet evaluated
Financial Overview — FY 2024
$13.1M
Total Revenue
$11.5M
Total Expenses
$50.6M
Net Assets
55
Employees
Revenue Sources
Expense Breakdown
Program Expense Ratio
86.1%
Fundraising Efficiency
737.5%
Operating Reserve
52.66x
Liability-to-Asset
6.3%
Revenue Diversification
94.1%
Executive Compensation
$672K
Compared with Peers
FY 2024
Compared with 98 similar organizations
(United States, Medical Research, $10M–$100M in expenses), FY 2024.
This organization
Middle half of peers (P25–P75)
Peer median
| Ratio | This org | Peer median | Position (P10 → P90) | |
|---|---|---|---|---|
|
Program expense ratio
Program expenses / total expenses
· higher is better
|
86.1% | 82.0% |
P10P90
|
Above median |
|
Admin expense ratio
Management and general / total expenses
· lower is better
|
4.7% | 12.7% |
P10P90
|
Top quarter |
|
Fundraising expense ratio
Fundraising expenses / total expenses
· lower is better
|
9.3% | 0.7% |
P10P90
|
Bottom quarter |
|
Fundraising efficiency
Fundraising expenses / gross fundraising income
· lower is better
|
737.5% | 693.4% |
P10P90
|
Below median |
|
Operating reserve
Months of expenses covered by net assets
· higher is better
|
52.7 mo | 14.5 mo |
P10P90
|
Top quarter |
|
Liabilities to assets
Total liabilities / total assets
· lower is better
|
6.3% | 21.3% |
P10P90
|
Top quarter |
|
Revenue concentration
Share of revenue from the largest source
· lower is better
|
94.1% | 90.8% |
P10P90
|
Below median |
|
Revenue growth
Year over year revenue growth
|
53.9% | 9.6% |
P10P90
|
|
|
Expense growth
Year over year expense growth
|
19.3% | 7.8% |
P10P90
|
|
|
Surplus margin
Surplus as a share of revenue
|
12.3% | -1.2% |
P10P90
|
Financial History
| Year | Revenue | Expenses | Net Assets | Program % | Staff |
|---|---|---|---|---|---|
| 2024 | $13.1M | $11.5M | $50.6M | 86.1% | 55 |
| 2023 | $8.5M | $9.7M | $45.1M | 81.1% | 47 |
| 2022 | $12.1M | $8.6M | N/A | — | 35 |
Donor Reviews
Write a ReviewNo reviews yet
Be the first to share your experience with this organization.